CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MacKay Life Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MacKay Life Sciences Inc
175 Strafford Ave
Phone: (215) 972-1717p:215 972-1717 WAYNE, PA  19087  United States Ticker: BZECBZEC

On 5/28/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of MacKay Life Sciences Inc. for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.

Business Summary
MacKay Life Sciences, Inc., formerly Biofield Corp. is a United States-based company, which is a development-stage medical technology company, which has developed an advanced medical device and associated diagnostic system, the Biofield Diagnostic System (BDS), to assist in detecting breast cancer, has secured marketing rights to products for treatment of oral and genital herpes and a diagnostic test for cervical cancer, and seeks to secure marketing rights for other complimentary products. The BDS employs single-use sensors of its own design, which are arranged on the skin surface in and around the quadrant of the breast where a suspicious lesion has been identified and in corresponding locations on the asymptomatic breast. Sensor readings are taken and analyzed using a pre-programmed algorithm to measure differentials, which may exist between test points.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201012/31/2009YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board JamesMacKay 53 1/1/2009 3/30/2006
Chief Executive Officer, Chief Financial Officer David B.Hong 62 1/1/2009 9/5/2008

Business Names
Business Name
Biofield Corp.
BZEC

General Information
Number of Employees: 1 (As of 12/31/2009)
Outstanding Shares: 52,858,699 (As of 9/8/2010)
Shareholders: 124
Stock Exchange: OTC
Federal Tax Id: 133703450
Fax Number: (770) 740-9366


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023